Study of Methicillin-resistant Staphylococcus Aureus (MRSA) Isolated From Infected Patients in Brazil (MRSABrazil)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2011 by University of Sao Paulo.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
University of Sao Paulo
ClinicalTrials.gov Identifier:
NCT01359358
First received: May 20, 2011
Last updated: May 23, 2011
Last verified: May 2011

May 20, 2011
May 23, 2011
July 2011
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT01359358 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Study of Methicillin-resistant Staphylococcus Aureus (MRSA) Isolated From Infected Patients in Brazil
Epidemiological Study of Methicillin-resistant Staphylococcus Aureus (MRSA) Isolated From Infected Patients During a Hospital Surveillance Period

This project has as general objective to determine if there is any Methicillin-resistant Staphylococcus aureus (MRSA) strain disseminating in the hospital of Belo Horizonte. If this is the case, the investigators will determine if this is an international known strain by typing it by PFGE and MLST.

The detection of mecA gene will be performed by PCR. Their susceptibility profile to several drugs will also be accessed and it will be possible to compare the response to those drugs commonly in use to that of Daptomycin, a new drug available in Brazil.

It will be screened for reduced susceptibility to vancomycin by Macromethod Etest (MET) in order to search for VISA or hetero-VISA. Also, due to the discussions at the literature about mutations in genes that are said to be responsible for reduced susceptibility to vancomycin, the investigators will sequence these genes in all PFGE type strain of this study looking for mutations already described to compare to the screening results.

Multidrug resistant and virulent MRSA strains have been disseminating worldwide and few alternatives of treatment for diseases caused by this pathogen are available. In this study, 36 isolates from colonization or different clinical specimens from infected patients of the Hospital Rizoleta Tolentino Neves will be analyzed. These results will provide important data for doctors and nurses, such as whether there is any strain dissemination or not in the hospital what could suggest an outbreak. It will be performed molecular typing by pulsed field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). The investigators will evaluate the efficiency of several antimicrobials and the frequency of h-VISA and VISA among the Brazilian MRSA. Besides, the investigators will verify the presence of mutation in genes that are involved in resistance mechanisms of VISA. According to the strains profile present in the hospital, if this is suggested that there is a dissemination of some strain, the health professionals can start a more rigid infection control measures in order to decrease the number of cases of nosocomial infection, decreasing the time of hospitalization of patients and, consequently the cost for the hospital.

Observational
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample

MRSA from infection or from colonization of a patient who was already infected by MRSA during the time of the study

Methicillin Resistant Staphylococcus Aureus
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
20
Not Provided
Not Provided

Inclusion Criteria:

  • MRSA from infection sites
  • MRSA from colonization of the patients who already was infected by MRSA during the time of the study

Exclusion Criteria:

  • MRSA from colonization of a patient who has not infection caused by MRSA
Both
1 Month and older
No
Contact: Hyllo Baeta MArcelo Jr, Master degree 55 31 99929631 hyllo@lustosa.com.br
Brazil
 
NCT01359358
Novartis IFSC-USP
Yes
Ilana Lopes Baratella da Cunha Camargo, University of Sao Paulo
University of Sao Paulo
Not Provided
Principal Investigator: Ilana L B Camargo, PhD University of Sao Paulo
University of Sao Paulo
May 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP